Public Health, Disease Prevention & WellnessNatera’s Fetal Focus sgNIPT Highlighted at SMFM MeetingBusiness WireJanuary 20, 2026January 21, 2026 by Business WireJanuary 20, 2026January 21, 2026028 EXPAND clinical trial to be presented; data support Fetal Focus™ sgNIPT for inherited conditions Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision...
